A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
University of Pittsburgh
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
AHS Cancer Control Alberta
University of Utah
Federal University of Rio Grande do Sul
Gamida Cell ltd
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Women's College Hospital
AronPharma Sp. z o. o.
Rhode Island Hospital
Rhode Island Hospital
Columbia University
Chungbuk National University
National Cancer Institute (NCI)